In oncology the treatment is very diversified right now – there’s surgery, chemotherapy, radiology, but also immunotherapy and targeted therapy. In this episode of SciLux we focus on the last two combined with some studies on gut microbiome and going back to genetics 101. Our guests, Patrick Dang who is Resident in oncology at CHL and doctoral student at LCSB/University of Luxembourg and Michael Dang, Resident in Oncology - Translational Medical Oncology at NCT Heidelberg are very good at explaining basics of their fields so you can count on an episode full of knowledge presented in a very approachable way.
SHOW NOTES
CHL - https://www.chl.lu/fr
LCSB - https://www.uni.lu/lcsb-en/
NCT Heidelberg - https://www.nct-heidelberg.de/en/index.html
More about Patrick's research project - https://www.cancer.lu/fr/projet-de-recherche-ImMi-Tx
The Bright Foundation co-founded by Patrick - https://brightfoundation.eu/